• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Lyra Therapeutics appoints new CFO

September 13, 2021 By Sean Whooley

Lyra Therapeutics LYR-210
LYR-210 is an investigational product designed to provide six months of anti-inflammatory treatment from a single in-office administration
(Image from Lyra Therapeutics)

Lyra Therapeutics (NSDQ:LYRA) announced today that it appointed Jason Cavalier as its new chief financial officer, effective today.

Cavalier succeeds the company’s current CFO, Don Elsey, who is retiring while he remains expected to serve in an advisory role to assist with the transition.

Watertown, Massachusetts-based Lyra — which develops the XTreo platform designed to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues — said in a news release that Cavalier’s role will involve leading the company’s financial and capital markets strategy, advising on business development and transactional activities and supporting investor and public relations.

“Jason brings over two decades of expertise in investment banking and corporate strategy and we are excited to welcome him to Lyra Therapeutics’ leadership team,” Lyra president & CEO Maria Palasis said in the release. “Jason’s insight into capital markets and corporate finance will be a valuable asset as we advance our lead programs, LYR-210 and LYR-220, into late-stage clinical development. We sincerely thank Don for his contributions to Lyra and wish him the best in retirement.”

Cavalier joins Lyra having most recently served as managing director and head of life sciences mergers & acquisitions at Cantor Fitzgerald. He previously held senior-level positions at RBC Capital Markets and served in investment banking roles at Barclays Capital, Bear Stearns and Lehman Brothers.

“Lyra’s XTreo technology is an innovative platform that has already demonstrated the potential to make a meaningful difference in the lives of the millions of patients suffering with chronic rhinosinusitis,” Cavalier said. “I believe it also holds impressive promise as a treatment for other chronic diseases where precise, sustained, local delivery of drug can provide a therapeutic advantage. I’m excited to join the Lyra leadership team as the company pursues the multi-billion-dollar CRS market opportunity and other indications in the future.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Implants, Otolaryngology Ear, Nose & Throat Tagged With: Lyra Therapeutics, Personnel, Personnel Moves

IN CASE YOU MISSED IT

  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Go-Pen ApS wins FDA nod for user-filled insulin pen

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS